These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18411260)

  • 1. Aggressiveness of cancer-care near the end-of-life in Korea.
    Keam B; Oh DY; Lee SH; Kim DW; Kim MR; Im SA; Kim TY; Bang YJ; Heo DS
    Jpn J Clin Oncol; 2008 May; 38(5):381-6. PubMed ID: 18411260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis.
    Braga S; Miranda A; Fonseca R; Passos-Coelho JL; Fernandes A; Costa JD; Moreira A
    Psychooncology; 2007 Sep; 16(9):863-8. PubMed ID: 17245696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends among gynecologic oncology inpatient deaths: is end-of-life care improving?
    Dalrymple JL; Levenback C; Wolf JK; Bodurka DC; Garcia M; Gershenson DM
    Gynecol Oncol; 2002 May; 85(2):356-61. PubMed ID: 11972400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
    von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
    Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC.
    Temel JS; McCannon J; Greer JA; Jackson VA; Ostler P; Pirl WF; Lynch TJ; Billings JA
    Cancer; 2008 Aug; 113(4):826-33. PubMed ID: 18618579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.
    Hashimoto K; Yonemori K; Katsumata N; Hotchi M; Kouno T; Shimizu C; Tamura K; Ando M; Takeuchi M; Fujiwara Y
    Oncologist; 2009 Jul; 14(7):752-9. PubMed ID: 19596665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of palliative care on cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths.
    Tse DM; Chan KS; Lam WM; Leu K; Lam PT
    Palliat Med; 2007 Jul; 21(5):425-33. PubMed ID: 17901102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy use and associated factors among cancer patients near the end of life.
    Yun YH; Kwak M; Park SM; Kim S; Choi JS; Lim HY; Lee CG; Choi YS; Hong YS; Kim SY; Heo DS
    Oncology; 2007; 72(3-4):164-71. PubMed ID: 18097167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospice and emergency room use by disadvantaged men dying of prostate cancer.
    Bergman J; Kwan L; Fink A; Connor SE; Litwin MS
    J Urol; 2009 May; 181(5):2084-9. PubMed ID: 19286207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilization for ovarian cancer patients at the end of life: how much is too much?
    Lewin SN; Buttin BM; Powell MA; Gibb RK; Rader JS; Mutch DG; Herzog TJ
    Gynecol Oncol; 2005 Nov; 99(2):261-6. PubMed ID: 16140364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utilization of palliative care in gynecologic oncology patients near the end of life.
    Fauci J; Schneider K; Walters C; Boone J; Whitworth J; Killian E; Straughn JM
    Gynecol Oncol; 2012 Oct; 127(1):175-9. PubMed ID: 22735789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. End-of-life care in lung cancer patients in Ontario: aggressiveness of care in the population and a description of hospital admissions.
    Barbera L; Paszat L; Qiu F
    J Pain Symptom Manage; 2008 Mar; 35(3):267-74. PubMed ID: 18248949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End of life care for women with gynecologic cancers.
    Barbera L; Elit L; Krzyzanowska M; Saskin R; Bierman AS
    Gynecol Oncol; 2010 Aug; 118(2):196-201. PubMed ID: 20466411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of palliative care services on the aggressiveness of end-of-life care in the Veteran's Affairs cancer population.
    Gonsalves WI; Tashi T; Krishnamurthy J; Davies T; Ortman S; Thota R; Aldoss I; Ganta A; Kalaiah M; Didwaniya N; Eberle C; Ganti AK; Silberstein PT; Subbiah S
    J Palliat Med; 2011 Nov; 14(11):1231-5. PubMed ID: 21877925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Palliative cancer care is an important part of urology. A study of the last year of life of patients who died because of urologic cancer].
    Bratt O; Nilsson T; Stenzelius K
    Lakartidningen; 2002 Feb; 99(8):765-7, 770. PubMed ID: 11894614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-of-life care for terminal head and neck cancer patients.
    Sesterhenn AM; Folz BJ; Bieker M; Teymoortash A; Werner JA
    Cancer Nurs; 2008; 31(2):E40-6. PubMed ID: 18490879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region].
    Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM
    Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of midazolam and haloperidol in cancer patients at the end of life.
    Radha Krishna LK; Poulose VJ; Goh C
    Singapore Med J; 2012 Jan; 53(1):62-6. PubMed ID: 22252186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of end-of-life care in low-income, uninsured men dying of prostate cancer.
    Bergman J; Chi AC; Litwin MS
    Cancer; 2010 May; 116(9):2126-31. PubMed ID: 20198706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing quality of end-of-life hospital care in a southern European regional health service.
    Aldasoro E; Alonso AP; Ribacoba L; Esnaola S; Olaizola M; Carrera JA; Bañuelos A; Rico R
    Int J Technol Assess Health Care; 2005; 21(4):464-70. PubMed ID: 16262969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.